secwatch / observer

Equity Issuances

Unregistered sales and modifications of equity under 8-K Items 3.02/3.03.

8-K items 3.02, 3.03 JSON
PALO PALOMA ACQUISITION CORP I

PALOMA ACQUISITION CORP I issued 350,000 units to the Sponsor and an aggregate of 150,000 units to Jefferies of unit to the Sponsor and an aggregate of 150,000 units to Jefferies for at a price of $10.00 per Private Placement Unit, generating gross proceeds of $5,000,000.

“On February 20, 2026, simultaneously with the consummation of the Offering, the Company consummated the private placement of 350,000 units to the Sponsor and an aggregate of 150,000 units to Jefferies (collectively, the “ Private Placement Units ”) at a price of $10.00 per Private Placement Unit, generating gross proceeds of $5,000,000 (the “ Private Placement ”).”
AMD ADVANCED MICRO DEVICES INC

ADVANCED MICRO DEVICES INC issued up to an aggregate of 160 million shares of common stock of warrant to Meta Platforms, Inc. for exercise price of $0.01 per share.

“AMD issued to Meta a performance-based warrant (the “Warrant”) to purchase up to an aggregate of 160 million shares of common stock of AMD (the “Warrant Shares”) at an exercise price of $0.01 per share.”
AGIG ABUNDIA GLOBAL IMPACT GROUP, INC.

ABUNDIA GLOBAL IMPACT GROUP, INC. issued 118,694 shares of Common Stock of warrant to Titan Partners Group LLC (placement agent) for issued to placement agent as compensation; exercise price equal to 110% of public offering price.

“issue to the Placement Agent placement agent warrants to purchase up to 118,694 shares of Common Stock, with an exercise price equal to 110% of the public offering price of the shares (the “Placement Agent Warrants”).”
AGIG ABUNDIA GLOBAL IMPACT GROUP, INC.

ABUNDIA GLOBAL IMPACT GROUP, INC. issued 1,800,543 shares of Common Stock of warrant to institutional investor for investor paid for pre-funded warrants as part of the offering; gross proceeds of approximately $20.0 million includes both shares and pre-funded warrants.

“Warrants”) to purchase up to 1,800,543 shares of Common Stock at an exercise price equal to $0.001 per share. The Company received gross proceeds of approximately $20.0 million before deducting the placement agent’s fees and related offering expenses. The Shares and the Pre-Funded Warrants were offered by the Company pursuant to a Registration Statement”
AGIG ABUNDIA GLOBAL IMPACT GROUP, INC.

ABUNDIA GLOBAL IMPACT GROUP, INC. issued 4,134,175 shares of common stock to institutional investor for approximately $20.0 million gross proceeds.

“Warrants”) to purchase up to 1,800,543 shares of Common Stock at an exercise price equal to $0.001 per share. The Company received gross proceeds of approximately $20.0 million before deducting the placement agent’s fees and related offering expenses. The Shares and the Pre-Funded Warrants were offered by the Company pursuant to a Registration Statement”
OLB OLB GROUP, INC.

OLB GROUP, INC. issued warrants to purchase up to 3,571,428 shares of Common Stock of warrant to an institutional investor for combined purchase price per Pre-Funded Warrant and accompanying Warrants of $1.05.

“Stock (the shares of Common Stock issuable upon exercise of the Warrants, the “Warrant Shares”), at a combined purchase price per Pre-Funded Warrant and accompanying Warrants of $1.05 (inclusive of the exercise price of $0.0001 to be paid upon exercise of each Pre-Funded Warrant) (the “Offering”). The Pre-Funded Warrants are immediately exercisable, will expire”
OLB OLB GROUP, INC.

OLB GROUP, INC. issued pre-funded warrants to purchase up to 2,857,142 shares of warrant to an institutional investor for combined purchase price per Pre-Funded Warrant and accompanying Warrants of $1.05.

“Stock (the shares of Common Stock issuable upon exercise of the Warrants, the “Warrant Shares”), at a combined purchase price per Pre-Funded Warrant and accompanying Warrants of $1.05 (inclusive of the exercise price of $0.0001 to be paid upon exercise of each Pre-Funded Warrant) (the “Offering”). The Pre-Funded Warrants are immediately exercisable, will expire”
TMRC Texas Mineral Resources Corp.

Texas Mineral Resources Corp. issued 6,187,472 shares of Common Stock of common stock to accredited investors.

“The issuance of the 6,187,472 shares of Common Stock upon the cashless, net issuance exercise of the Warrants issued in connection with the February 2025 transaction, as disclosed in Item 8.01 below (which disclosure in Item 8.01 is incorporated herein by reference), was issued in accordance with the disclosure set forth in Item 3.02 of the February 2025 Forms 8-K.”
SILO Silo Pharma, Inc.

Silo Pharma, Inc. issued 848,320 shares of Common Stock of common stock to investor relations consultant for commitment fee of $250,000.

“On February 20, 2026, Silo Pharma, Inc. (the “Company”) entered into an addendum to Service Agreement with its investor relations consultant pursuant to which is agreed to pay such consultant a commitment fee of $250,000 (the “Commitment Fee”) in consideration of entering into the addendum and restarting the service agreement. The consultant elected to receive the Commitment Fee in shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”) resulting in 848,320 shares of Common Stock payable to the consultant in respect of the Commitment Fee based on a $0.2947 share price”
ATRA Atara Biotherapeutics, Inc.

Atara Biotherapeutics, Inc. issued up to 400,000 shares of the Company's Common Stock of warrant to HCR Molag Fund, L.P. for exercise price is equal to $0.0001 per share.

“the Company issued a warrant to purchase up to 400,000 shares of the Company's Common Stock (the “Warrant”). The exercise price of the Warrant is equal to $0.0001 per share, subject to adjustment as provided therein, and the Warrants will be exercisable immediately and has no expiration date.”
VIR Vir Biotechnology, Inc.

Vir Biotechnology, Inc. issued 7,239,382 shares of common stock to Astellas for an aggregate purchase price of approximately $75 million.

“Astellas has agreed to purchase 7,239,382 shares of Vir Bio’s common stock, par value $0.0001 per share (Common Stock), for an aggregate purchase price of approximately $75 million”
GAME GameSquare Holdings, Inc.

GameSquare Holdings, Inc. issued 5,000,000 shares of Series A-2 Convertible Preferred Stock of preferred stock to Ben Group, Inc. and TubeBuddy, LLC for issued in connection with asset purchase agreement for substantially all assets of Seller relating to software.

“In connection with the Transaction, on February 20, 2026, the Company filed the Certificate of Designation of Series A-2 Convertible Preferred Stock (the “Certificate of Designation”) with the Secretary of State of Delaware, which designated 5,000,000 shares of Series A-2 Preferred Stock.”
IBATF INTERNATIONAL BATTERY METALS LTD.

INTERNATIONAL BATTERY METALS LTD. issued 26,427,053 Units of unit to EV Metals 9 LLC for USD $0.08 per Unit.

“("LOI") with EV Metals 7 LLC from March 2025. Each Unit includes one Company common share and one warrant (each, a "Warrant") to purchase one common share and is priced at USD $0.08 per Unit, with total gross proceeds of USD $2.0 million. Each Warrant entitles the holder to purchase one additional Company common share at a price of C$0.14 per share for a”
Apollo Debt Solutions BDC

Apollo Debt Solutions BDC issued 2,034,936 of common stock to feeder vehicles primarily created to hold the Fund’s Class I Common Shares for $49,525,042.

“the shares sold: Date of Unregistered Sale Amount of Class I Common Shares Consideration As of February 2, 2026 (number of shares finalized on February 23, 2026) 2,034,936 $ 49,525,042”
First Eagle Private Credit Fund

First Eagle Private Credit Fund issued 306 of common stock to a feeder vehicle primarily created to hold the Fund’s common shares for $7,360.

“details the shares sold: Date of Unregistered Sale Amount of Class I Common Shares Consideration As of February 1, 2026 (number of shares finalized on February 23, 2026) 306 $ 7,360”
KKR FS Income Trust

KKR FS Income Trust issued 2,187,655.524 Class I shares of common stock to accredited investors for aggregate consideration of approximately $64.885 million.

“On February 2, 2026, KKR FS Income Trust (the “Company”) issued and sold 2,187,655.524 Class I shares (the “Class I Shares”) of the Company’s common shares of beneficial interest (the “Shares”) (with the final number of Class I Shares issued being determined on February 23, 2026) pursuant to subscription agreements entered into with the participating investors for aggregate consideration of approximately $64.885 million”
KKR FS Income Trust Select

KKR FS Income Trust Select issued 1,004,296.392 Class I shares of common stock to accredited investors for aggregate consideration of approximately $25.619 million.

“On February 2, 2026, KKR FS Income Trust Select (the “Company”) issued and sold 1,004,296.392 Class I shares (the “Class I Shares”) of the Company’s common shares of beneficial interest (the “Shares”) (with the final number of Class I Shares issued being determined on February 23, 2026) pursuant to subscription agreements entered into with the participating investors for aggregate consideration of approximately $25.619 million .”
SL Investment Fund II LLC

SL Investment Fund II LLC issued approximately 3,654,035 shares of common stock to accredited investors for $74.25 million.

“On February 10, 2026, the Company delivered a capital drawdown notice to its unitholders relating to the sale of approximately 3,654,035 shares of the Company’s common units, par value $0.001 per share (the “Common Units”) for an aggregate offering price of $74 .25 million. T he sale closed on February 18, 2026.”
INR INFINITY NATURAL RESOURCES, INC.

INFINITY NATURAL RESOURCES, INC. issued 350,000 shares of Series A Convertible Preferred Stock of preferred stock to affiliates of Quantum Capital Group and affiliates of Carnelian Energy Capital Management, L.P. for $1,000 per share for an aggregate purchase price of $350 million.

“defined below) 350,000 shares of newly designated Series A Convertible Preferred Stock of the Company, par value $0.01 per share (the “Series A Preferred Stock”), at a price of $1,000 per share (the “Initial Liquidation Preference”) for an aggregate purchase price of $350 million (the “Preferred Investment”). The Securities Purchase Agreement contains customary”
EQT Infrastructure Co LLC

EQT Infrastructure Co LLC issued approximately 997,242 Class E Shares of preferred stock to EQT Holdings AB for valued at $25.00 per Class E Share.

“On February 20, 2026, EQT Infrastructure Company LLC (the “Company”) issued to EQT Holdings AB, an indirect subsidiary of EQT AB, a total of approximately 997,242 Class E Shares of the Company (the “Class E Shares”), valued at $25.00 per Class E Share, in exchange for the contribution to the Company of ownership interests in Constellation Cold Logistics S.à r.l., a provider of temperature-controlled storage infrastructure.”
AACI Armada Acquisition Corp. III

Armada Acquisition Corp. III issued 672,000 private placement units of unit to Armada Sponsor III LLC for $10.00 per Private Placement Unit generating aggregate gross proceeds of $6,720,000.

“On the Closing Date, simultaneously with the consummation of the IPO, pursuant to the Private Placement Purchase Agreements, the Company completed the private sale (the “Private Placement”) of an aggregate of 672,000 private placement units (the “Private Placement Units”) to the Sponsor and the Representatives, at a price of $10.00 per Private Placement Unit generating aggregate gross proceeds of $6,720,000.”
EP EMPIRE PETROLEUM CORP

EMPIRE PETROLEUM CORP issued convertible note to Phil E. Mulacek for $3,000,000 aggregate principal amount.

“On February 19, 2026, Empire Petroleum Corporation (the “Company”) issued that certain Promissory Note in the aggregate principal amount of $3,000,000 (the “Note”) to Phil E. Mulacek.”
MIAX MIAMI INTERNATIONAL HOLDINGS, INC.

MIAMI INTERNATIONAL HOLDINGS, INC. issued 2,150,894 shares of common stock of common stock to a certain warrant holder for Surrender of 106 shares of Common Stock pursuant to cashless exercise of a warrant.

“Since February 9, 2026, the end of the period covered by the most recent report filed on any of Forms 8-K, 10-K or 10-Q under this Item 3.02 by Miami International Holdings, Inc. (the “Company”), through February 18, 2026, the Company issued a total of 2,150,894 shares of its common stock, par value $0.001 per share (“Common Stock”), in connection with the partial exercise of a pre-funded warrant by a certain warrant holder of the Company in consideration for the surrender of 106 shares of Common Stock pursuant to a cashless exercise.”
AB Private Credit Investors Corp

AB Private Credit Investors Corp issued common stock for $9,275,912.33.

“On February 19, 2026, AB Private Credit Investors Corporation (the “ Fund ”) delivered a capital call notice to its investors relating to shares of the Fund’s common stock, par value $0.01 per share (the “ Shares ”), for an aggregate offering price of $9,275,912.33.”
SIGY Sigyn Therapeutics, Inc.

Sigyn Therapeutics, Inc. issued convertible note to Lambda Venture Partners, LLC for $27,777.77 principal amount, $21,500.00 net proceeds.

“On February 6, 2026, Sigyn Therapeutics, Inc. (the “Company”) entered into a one-year Convertible Note Purchase Agreement (the “Purchase Agreement”) with Lambda Venture Partners, LLC, in the principal amount of $27,777.77, which resulted in net proceeds of $21,500.00 to the Company after the payment of related legal fees.”
SIGY Sigyn Therapeutics, Inc.

Sigyn Therapeutics, Inc. issued convertible note to Osher Capital Partners, LLC for $22,222.22 principal amount, $20,000.00 gross proceeds.

“On February 12, 2026, Sigyn Therapeutics, Inc. (the “Company”) entered into a one-year Convertible Note Purchase Agreement (the “Purchase Agreement”) with Osher Capital Partners, LLC, in the principal amount of $22,222.22, which resulted in gross proceeds of $20,000.00 to the Company.”
SIGY Sigyn Therapeutics, Inc.

Sigyn Therapeutics, Inc. issued convertible note to Brio Capital Master Fund, Ltd for $22,222.22 principal amount, $20,000.00 gross proceeds.

“On February 12, 2026, Sigyn Therapeutics, Inc. (the “Company”) entered into a one-year Convertible Note Purchase Agreement (the “Purchase Agreement”) with Brio Capital Master Fund, Ltd, in the principal amount of $22,222.22, which resulted in gross proceeds of $20,000.00 to the Company.”
MBRX Moleculin Biotech, Inc.

Moleculin Biotech, Inc. issued up to 6,367,956 shares of Company common stock of warrant to holders of certain existing warrants.

“The Company issued the Inducement Warrants pursuant to the exemption from the registration requirements of the Securities Act available under Section 4(a)(2).”
Monroe Capital Income Plus Corp

Monroe Capital Income Plus Corp issued 2,597,869 shares of common stock to each investor in the registrant for $9.87 per share.

“On February 2, 2026, Monroe Capital Income Plus Corporation (the "Company") issued an aggregate of 2,597,869 shares of its common stock, par value $0.01 per share (the “Common Stock”), at a price per share of $9.87 (with the final number of shares being determined on February 20, 2026), for an aggregate offering price of $25,640,965.”
Blackstone Private Credit Fund

Blackstone Private Credit Fund issued 7,509,040 of common stock for $185,323,110.

“the shares sold: Date of Unregistered Sale Amount of Class I Common Shares Consideration As of February 1, 2026 (number of shares finalized on February 19, 2026) 7,509,040 $ 185,323,110”
FFAI FARADAY FUTURE INTELLIGENT ELECTRIC INC.

FARADAY FUTURE INTELLIGENT ELECTRIC INC. issued increase in the number of authorized shares of preferred stock, par value $0.0001 per share, of the Company from 17,931,000 to 24,087,265 shares of preferred stock.

“On February 18, 2026, Faraday Future Intelligent Electric Inc. (the “Company”) filed an amendment (the “Certificate of Amendment”) to the Company’s Third Amended and Restated Certificate of Incorporation (as amended, the “Charter”) with the office of the Secretary of State of the State of Delaware (the “Delaware SOS”) to effect (i) an increase in the number of authorized shares of common stock, par value $0.0001 per share, of the Company (“FFAI Common Stock”) from 232,470,985 to 312,285,439 shares, and (ii) an increase in the number of authorized shares of preferred stock, par value $0.0001 per share, of the Company (“FFAI Preferred Stock”) from 17,931,000 to 24,087,265 shares, increasing the total number of authorized shares of FFAI Common Stock and FFAI Preferred Stock from 250,401,985 shares to 336,372,704 shares.”
FFAI FARADAY FUTURE INTELLIGENT ELECTRIC INC.

FARADAY FUTURE INTELLIGENT ELECTRIC INC. issued increase in the number of authorized shares of common stock, par value $0.0001 per share, of the Company from 232,470,985 to 312,285,439 shares of common stock.

“On February 18, 2026, Faraday Future Intelligent Electric Inc. (the “Company”) filed an amendment (the “Certificate of Amendment”) to the Company’s Third Amended and Restated Certificate of Incorporation (as amended, the “Charter”) with the office of the Secretary of State of the State of Delaware (the “Delaware SOS”) to effect (i) an increase in the number of authorized shares of common stock, par value $0.0001 per share, of the Company (“FFAI Common Stock”) from 232,470,985 to 312,285,439 shares, and (ii) an increase in the number of authorized shares of preferred stock, par value $0.0001 per share, of the Company (“FFAI Preferred Stock”) from 17,931,000 to 24,087,265 shares, increasing the total number of authorized shares of FFAI Common Stock and FFAI Preferred Stock from 250,401,985 shares to 336,372,704 shares.”
SCLX Scilex Holding Co

Scilex Holding Co issued 100,000 shares of the Company’s common stock of warrant to Oramed Pharmaceuticals Inc..

“the issuance of the February 2026 Warrant was made, and the issuance of the shares of Common Stock underlying the February 2026 Warrants will be made, in reliance on the exemption from registration pursuant to Section 4(a)(2) of the Securities Act and Regulation D promulgated thereunder”
AB Private Lending Fund

AB Private Lending Fund issued 126,671 of common stock to feeder vehicles primarily created to hold the Fund's Class I shares for $ 3,184,398.50.

“table details the shares sold: Date of Unregistered Sale Amount of Class I shares Consideration As of February 2, 2026 (number of shares finalized on February 20, 2026) 126,671 $ 3,184,398.50”
North Haven Net REIT

North Haven Net REIT issued 223,772 Class I shares and 4,369 Class F-I shares of common stock to a feeder vehicle primarily created to hold certain classes of the Company's common shares for aggregate consideration of approximately $4,592,000 and $90,000, respectively.

“sold an aggregate of 223,772 Class I shares and 4,369 Class F-I shares (the "Shares") (with the final number of Shares being determined on February 13, 2026) for aggregate consideration of approximately $4,592,000 and $90,000, respectively, based on the net asset value per share as of January 31, 2025, to a feeder vehicle primarily created to hold certain classes of the Company's common shares”
Stone Point Credit Income Fund

Stone Point Credit Income Fund issued 1,352,532.575 shares of common stock to accredited investors for $25.0267 per share.

“On February 1, 2026 (with the final number of shares being determined on February 18, 2026), Stone Point Credit Income Fund (the “Fund”) issued and sold 1,352,532.575 shares of the Fund’s common shares, par value $0.001 per share (the “Common Shares”), at a net asset value of $25.0267, pursuant to the subscription agreements entered into by the Fund and its investors, for an aggregate offering price of $33,849,427.00.”
INTEGRATED RAIL & RESOURCES INC.

INTEGRATED RAIL & RESOURCES INC. issued 50,000 shares of its Series A Convertible Preferred Stock of preferred stock to Creto IRRX PIPE Investment, LLC for gross proceeds of approximately $5,000,000.

“On January 23, 2026 (the “Closing Date”), Integrated Rail & Resources Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with Creto IRRX PIPE Investment, LLC (the “Investor”), pursuant to which the Company agreed to sell an aggregate of 50,000 shares of its Series A Convertible Preferred Stock, par value $0.0001 per share and stated value $100.00 per share (the “Preferred Stock”), for gross proceeds of approximately $5,000,000 in a private placement.”
Ares Sports, Media & Entertainment Opportunities LP

Ares Sports, Media & Entertainment Opportunities LP issued unit to accredited investors and qualified purchasers for aggregate cash consideration of approximately $25.2 million.

“On February 1, 2026, Ares Sports, Media and Entertainment Opportunities LP (the “Fund”) sold unregistered limited partnership units (the “Units”) for aggregate consideration of approximately $25.2 million.”
Blue Owl Digital Infrastructure Trust

Blue Owl Digital Infrastructure Trust issued 4,188,035 of its common shares of common stock for gross proceeds of approximately $42.4 million.

“On February 2, 2026, Blue Owl Digital Infrastructure Trust (the “Company”) sold an aggregate of 4,188,035 of its common shares (with the final number of shares being determined on February 17, 2026) for gross proceeds of approximately $42.4 million”
ACAA Averin Capital Acquisition Corp.

Averin Capital Acquisition Corp. issued 200,000 units of unit to Averin Capital Acquisition Sponsor LLC for $10.00 per Private Placement Unit.

“Simultaneously with the closing of the IPO, pursuant to the Sponsor Private Placement Units Purchase Agreement, the Company completed the private sale of an aggregate of 200,000 units (the “ Private Placement Units ”) to the at a price of $10.00 per Private Placement Unit.”
AACO Abony Acquisition Corp. I

Abony Acquisition Corp. I issued 695,000 Private Placement Units of unit to the Sponsor and the Representative for $10.00 per Private Placement Unit, generating gross proceeds of $6,950,000.

“On February 20, 2026, simultaneously with the consummation of the Offering, the Company consummated the private placement of 465,000 units to the Sponsor and an aggregate of 230,000 units to the Representative (collectively, the “Private Placement Units”) at a price of $10.00 per Private Placement Unit, generating gross proceeds of $6,950,000 (the “Private Placement”).”
VNRX VOLITIONRX LTD

VOLITIONRX LTD issued warrants to purchase up to an additional 483,870 shares of common stock of warrant to an existing stockholder for combined offering price of $0.62 per share and accompanying warrant, or an aggregate offering price of $300,000.

“on September 18, 2025 the Company issued 483,870 shares of its common stock, plus warrants to purchase up to an additional 483,870 shares of common stock at an exercise price of $0.682 per share, to an existing stockholder in a private placement, at a combined offering price of $0.62 per share and accompanying warrant, or an aggregate offering price of $300,000”
VNRX VOLITIONRX LTD

VOLITIONRX LTD issued 483,870 shares of its common stock of common stock to an existing stockholder for combined offering price of $0.62 per share and accompanying warrant, or an aggregate offering price of $300,000.

“on September 18, 2025 the Company issued 483,870 shares of its common stock, plus warrants to purchase up to an additional 483,870 shares of common stock at an exercise price of $0.682 per share, to an existing stockholder in a private placement, at a combined offering price of $0.62 per share and accompanying warrant, or an aggregate offering price of $300,000”
VNRX VOLITIONRX LTD

VOLITIONRX LTD issued 1,893,936 shares of common stock of common stock to Lind Global Asset Management XII LLC for $416,666 payment obligation.

“on January 16, 2026, the Company issued to Lind an aggregate of 1,893,936 shares of common stock to satisfy a $416,666 payment obligation”
VNRX VOLITIONRX LTD

VOLITIONRX LTD issued 2,569,753 shares of common stock of common stock to Lind Global Asset Management XII LLC for $583,334 payment obligation.

“on January 29, 2026, the Company issued to Lind an aggregate of 2,569,753 shares of common stock to satisfy a $583,334 payment obligation”
VNRX VOLITIONRX LTD

VOLITIONRX LTD issued 1,956,178 shares of common stock of common stock to Lind Global Asset Management XII LLC for $416,666 payment obligation.

“on February 17, 2026, the Company issued to Lind an aggregate of 1,956,178 shares of common stock to satisfy a $416,666 payment obligation”
STX Seagate Technology Holdings plc

Seagate Technology Holdings plc issued 5,952,309 ordinary shares of common stock to holders of $600 million principal amount of exchangeable notes for $599.2 million in cash and approximately 5.95 million ordinary shares.

“the aggregate of 5,952,309 ordinary shares issued in the Exchanges were issued pursuant to the exemption from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), afforded by Section 4(a)(2) of the Securities Act in transactions not involving any public offering.”
IRD Opus Genetics, Inc.

Opus Genetics, Inc. issued 7,374,632 shares of its Series B Non-Voting Convertible Preferred Stock of preferred stock to certain purchasers for $3.39 per share for an aggregate purchase price of approximately $25.0 million.

“The Private Placement closed on February 18, 2026. Pursuant to the Securities Purchase Agreement, the Purchasers purchased the Series B Preferred Stock at a purchase price of $3.39 per share for an aggregate purchase price of approximately $25.0 million. The Company expects to use the net proceeds from the Private Placement to advance its gene therapy”
BLNE Beeline Holdings, Inc.

Beeline Holdings, Inc. issued acquired an aggregate of 337,967 shares of the Company’s common stock of warrant to four warrant holders.

“On February 5, 2026 and February 12, 2026, four warrant holders exercised their Series G Warrants to purchase Common Stock and acquired an aggregate of 337,967 shares of the Company’s common stock.”
BLNE Beeline Holdings, Inc.

Beeline Holdings, Inc. issued converted certain shares of the Company’s Series F Convertible Preferred Stock, Series F-1 Convertible Preferred Stock and Series G Convertible Preferred Stock of preferred stock to various shareholders.

“From January 28, 2026 through February 16, 2026, various shareholders converted certain shares of the Company’s Series F Convertible Preferred Stock, Series F-1 Convertible Preferred Stock and Series G Convertible Preferred Stock into a total of 94,476 shares of the Company’s common stock.”

Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.